PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX)
The paper presents data on the effectiveness, safety, tolerance, major mechanisms of action, and prospects for clinically using meloxicam, a current selective nonsteroidal anti-inflammatory drug, against cyclooxygenase-2. It describes the advantages of meloxicam for injections, which begins acting p...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2008-12-01
|
| Series: | Современная ревматология |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/194 |
| _version_ | 1797876862330863616 |
|---|---|
| author | M S Eliseev M S Eliseyev |
| author_facet | M S Eliseev M S Eliseyev |
| author_sort | M S Eliseev |
| collection | DOAJ |
| description | The paper presents data on the effectiveness, safety, tolerance, major mechanisms of action, and prospects for clinically using meloxicam, a current selective nonsteroidal anti-inflammatory drug, against cyclooxygenase-2. It describes the advantages of meloxicam for injections, which begins acting promptly and shows an adequate long analgesic effect. |
| first_indexed | 2024-04-10T02:09:13Z |
| format | Article |
| id | doaj.art-02e8898d5fc84a8b99b9427727a38889 |
| institution | Directory Open Access Journal |
| issn | 1996-7012 2310-158X |
| language | Russian |
| last_indexed | 2024-04-10T02:09:13Z |
| publishDate | 2008-12-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj.art-02e8898d5fc84a8b99b9427727a388892023-03-13T08:39:20ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2008-12-0124545610.14412/1996-7012-2008-5091499PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX)M S EliseevM S EliseyevThe paper presents data on the effectiveness, safety, tolerance, major mechanisms of action, and prospects for clinically using meloxicam, a current selective nonsteroidal anti-inflammatory drug, against cyclooxygenase-2. It describes the advantages of meloxicam for injections, which begins acting promptly and shows an adequate long analgesic effect.https://mrj.ima-press.net/mrj/article/view/194 |
| spellingShingle | M S Eliseev M S Eliseyev PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) Современная ревматология |
| title | PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) |
| title_full | PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) |
| title_fullStr | PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) |
| title_full_unstemmed | PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) |
| title_short | PBOSPECTS FOR CLINICAL APPLICATION OF THE CURRENT ANTI-INFLAMMATORY DRUG MELOXICAM (AMELOTEX) |
| title_sort | pbospects for clinical application of the current anti inflammatory drug meloxicam amelotex |
| url | https://mrj.ima-press.net/mrj/article/view/194 |
| work_keys_str_mv | AT mseliseev pbospectsforclinicalapplicationofthecurrentantiinflammatorydrugmeloxicamamelotex AT mseliseyev pbospectsforclinicalapplicationofthecurrentantiinflammatorydrugmeloxicamamelotex |